Wilson's disease is an autosomal recessive inherited disorder of copper met
abolism resulting in pathological accumulation of copper in many organs and
tissues. The Wilson disease gene is localized on human chromosome 13 and c
odes for a copper transporting P-type ATPase, - ATP7B, About one hundred mu
tations occurring throughout the whole gene have been documented so far: Th
e most common is the His1069Gln point mutation. Wilson's disease may presen
t under a variety; of clinical conditions, the most common being liver dise
ase (ranging from. acute hepatitis, fulminant hepatic failure, chronic hepa
titis, and cirrhosis), haemolytic anaemia, and neuropsychiatric ic disturba
nces. The diagnosis of Wilson's disease is usually made on the basis of cli
nical findings (Kayser-Fleischer rings, typical neurologic symptoms) and la
boratory abnormalities (low serum caeruloplasmin, increased hepatic copper
content). Molecular genetic testing is now the standard for testing asympto
matic siblings. Diagnosis in patients presenting with liver diseases is dif
ficult and requires a combination of various laboratory parameters. Lifelon
g treatment with chelating agents (d-penicillamine, trientine) or,vith zinc
is usually sufficient to stabilize the patient and to achieve clinical rem
ission in most. Patients with advanced liver disease benefit from orthotopi
c liver transplantation.